Li Z, Bai R, Yi J, Zhou H, Xian J, Chen C
Chem Biomed Imaging. 2023; 1(4):315-339.
PMID: 37501794
PMC: 10369497.
DOI: 10.1021/cbmi.3c00026.
Simeckova P, Hubatka F, Kotoucek J, Knotigova P, Masek J, Slavik J
Sci Rep. 2020; 10(1):4780.
PMID: 32179785
PMC: 7075985.
DOI: 10.1038/s41598-020-60284-z.
Mondjinou Y, Loren B, Collins C, Hyun S, Demoret A, Skulsky J
Bioconjug Chem. 2018; 29(11):3550-3560.
PMID: 30403467
PMC: 8404830.
DOI: 10.1021/acs.bioconjchem.8b00525.
Lux J, Sherry A
Curr Opin Chem Biol. 2018; 45:121-130.
PMID: 29751253
PMC: 6076858.
DOI: 10.1016/j.cbpa.2018.04.006.
Jackson A, Chandrasekharan P, Shi J, Rannard S, Liu Q, Yang C
Int J Nanomedicine. 2015; 10:5895-907.
PMID: 26425088
PMC: 4583124.
DOI: 10.2147/IJN.S88764.
Magnetic Nanoparticles for Early Detection of Cancer by Magnetic Resonance Imaging.
Lin W, Hyeon T, Lanza G, Zhang M, Meade T
MRS Bull. 2015; 34(6):441-448.
PMID: 26166945
PMC: 4495966.
DOI: 10.1557/mrs2009.120.
A cell-permeable gadolinium contrast agent for magnetic resonance imaging of copper in a Menkes disease model.
Que E, New E, Chang C
Chem Sci. 2014; 3(6):1829-1834.
PMID: 25431649
PMC: 4243178.
DOI: 10.1039/C2SC20273E.
Lipid- and polymer-based nanostructures for cancer theranostics.
Luk B, Fang R, Zhang L
Theranostics. 2013; 2(12):1117-26.
PMID: 23382770
PMC: 3563151.
DOI: 10.7150/thno.4381.
Folate receptor-targeted fluorescent paramagnetic bimodal liposomes for tumor imaging.
Ding N, Lu Y, Lee R, Yang C, Huang L, Liu J
Int J Nanomedicine. 2011; 6:2513-20.
PMID: 22072885
PMC: 3205144.
DOI: 10.2147/IJN.S23934.
Biocompatible Polyhydroxyethylaspartamide-based Micelles with Gadolinium for MRI Contrast Agents.
Jeong S, Kim H, Kwak B, Lee H, Seong H, Shin B
Nanoscale Res Lett. 2010; 5(12):1970-6.
PMID: 21170410
PMC: 2991228.
DOI: 10.1007/s11671-010-9734-7.
Biomedical Nanomagnetics: A Spin Through Possibilities in Imaging, Diagnostics, and Therapy.
Krishnan K
IEEE Trans Magn. 2010; 46(7):2523-2558.
PMID: 20930943
PMC: 2949969.
DOI: 10.1109/TMAG.2010.2046907.
Paramagnetic and fluorescent liposomes for target-specific imaging and therapy of tumor angiogenesis.
Strijkers G, Kluza E, van Tilborg G, van der Schaft D, Griffioen A, Mulder W
Angiogenesis. 2010; 13(2):161-73.
PMID: 20390447
PMC: 2911540.
DOI: 10.1007/s10456-010-9165-1.
Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics.
Villaraza A, Bumb A, Brechbiel M
Chem Rev. 2010; 110(5):2921-59.
PMID: 20067234
PMC: 2868950.
DOI: 10.1021/cr900232t.
Gadolinium-containing phosphatidylserine liposomes for molecular imaging of atherosclerosis.
Maiseyeu A, Mihai G, Kampfrath T, Simonetti O, Sen C, Roy S
J Lipid Res. 2008; 50(11):2157-63.
PMID: 19017616
PMC: 2759821.
DOI: 10.1194/jlr.M800405-JLR200.
Multifunctional and stimuli-sensitive pharmaceutical nanocarriers.
Torchilin V
Eur J Pharm Biopharm. 2008; 71(3):431-44.
PMID: 18977297
PMC: 3197821.
DOI: 10.1016/j.ejpb.2008.09.026.
Targeted pharmaceutical nanocarriers for cancer therapy and imaging.
Torchilin V
AAPS J. 2007; 9(2):E128-47.
PMID: 17614355
PMC: 2751402.
DOI: 10.1208/aapsj0902015.
Enhanced accumulation of long-circulating liposomes modified with the nucleosome-specific monoclonal antibody 2C5 in various tumours in mice: gamma-imaging studies.
Elbayoumi T, Torchilin V
Eur J Nucl Med Mol Imaging. 2006; 33(10):1196-205.
PMID: 16763815
DOI: 10.1007/s00259-006-0139-x.
Paramagnetic liposomes containing amphiphilic bisamide derivatives of Gd-DTPA with aromatic side chain groups as possible contrast agents for magnetic resonance imaging.
Parac-Vogt T, Kimpe K, Laurent S, Pierart C, Vander Elst L, Muller R
Eur Biophys J. 2005; 35(2):136-44.
PMID: 16217648
DOI: 10.1007/s00249-005-0024-8.
Monitoring the intragastric distribution of a colloidal drug carrier model by magnetic resonance imaging460.
Faas H, Schwizer W, Feinle C, Lengsfeld H, de Smidt C, Boesiger P
Pharm Res. 2001; 18(4):460-6.
PMID: 11451032
DOI: 10.1023/a:1011098125916.
Liposomes in drug delivery. Clinical, diagnostic and ophthalmic potential.
Gregoriadis G, Florence A
Drugs. 1993; 45(1):15-28.
PMID: 7680982
DOI: 10.2165/00003495-199345010-00003.